Although considered a single class, fecal immunochemical tests (FITs) vary in their ability to detect advanced colorectal neoplasia (ACN) and should not be considered interchangeable, new research ...

Medically reviewed by Gagandeep Brar, MD An at-home FIT test is a screening tool that may detect colon cancer. It works by ...

More than 10% of fecal immunochemical test (FIT)–based colorectal cancer screening could not be processed due to unsatisfactory samples. Colorectal cancer (CRC) screening using the fecal ...

Automated text message reminders with embedded behavioral nudges are linked to higher colorectal cancer screening completion ...

Colorectal cancer (CRC) remains a major global health challenge, with early detection proving essential for effective treatment and improved patient outcomes. Fecal immunochemical testing (FIT) has ...

Three-quarters of people prefer to do a fecal immunochemical test (FIT) rather than a colonoscopy for their regular colorectal cancer screening, according to a new Cedars-Sinai study. Unlike ...

Commercial FITs can match NG-MSDT diagnostic results for CRC by lowering the positivity threshold, enhancing sensitivity while maintaining specificity. FITs are accessible, noninvasive CRC screening ...

Fecal immunochemical testing, which tests for human blood in a patient’s stool, is now available as a take-home test from Life Line Screening, according to a company news release. The test requires no ...

These are the FDA-approved options to test for prostate, colorectal, and cervical cancer.

Colorectal cancer (CRC) remains the second leading cause of cancer-related deaths in the United States, a troubling fact when considering that CRC is largely preventable and treatable if caught early.

We conducted a prospective cohort study among 5,598 participants age 40-74 years between 2012 and 2020 in Tianjin, China. Inverse probability weighting was adopted to adjust for potential imbalanced ...